StockWatch
·

BACIL PHARMA LTD. Q4 FY25 Results

BACPHARQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue0.00
Total Income0.092823.3%
Expenditure0.0712.8%
PBT0.02125.0%
Net Profit0.02125.0%
OPM—
NPM17.67%
EPS0.20300.0%
View full financials

Informational and educational content only. Not investment advice.